Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C15H24N6O4 |
| Molecular Weight | 352.3889 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@H](N)C(=O)OCC[C@@H](CO)CN1C=NC2=C1NC(N)=NC2=O
InChI
InChIKey=ATSZELKUSAREPW-ZJUUUORDSA-N
InChI=1S/C15H24N6O4/c1-8(2)10(16)14(24)25-4-3-9(6-22)5-21-7-18-11-12(21)19-15(17)20-13(11)23/h7-10,22H,3-6,16H2,1-2H3,(H3,17,19,20,23)/t9-,10+/m1/s1
| Molecular Formula | C15H24N6O4 |
| Molecular Weight | 352.3889 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Omaciclovir (previously known as H2G), a cyclic guanosine analog that is structurally similar to acyclovir and was in clinical development for the treatment of herpesvirus infections. This drug acted against varicella-zoster virus (VZV), by the formation of high concentrations of relatively stable H2G-triphosphate, which is a potent inhibitor of the viral DNA polymerases. However, further development of this drug was discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil. | 1998 Dec |
|
| Effect of (r)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) and AZT-lipid-PFA on human herpesvirus-6B infected cells. | 2009 Sep |
|
| Activity of H2G on human herpesvirus-6B strains either sensitive or resistant to ganciclovir. | 2010 Jun |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:30:48 GMT 2023
by
admin
on
Fri Dec 15 15:30:48 GMT 2023
|
| Record UNII |
F094Y61748
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29575
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
||
|
NCI_THESAURUS |
C1556
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
||
|
NCI_THESAURUS |
C281
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000034432
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY | |||
|
7983
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY | |||
|
DB06575
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY | |||
|
C96764
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107301
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY | |||
|
DTXSID90941276
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY | |||
|
C513295
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY | |||
|
135544014
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY | |||
|
195157-34-7
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY | |||
|
F094Y61748
Created by
admin on Fri Dec 15 15:30:48 GMT 2023 , Edited by admin on Fri Dec 15 15:30:48 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
METABOLITE ACTIVE -> PRODRUG |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|